These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 8999136

  • 1. [In vitro anti-MAC activities of new quinolones in focus (1)].
    Tsuyuguchi K.
    Kekkaku; 1996 Sep; 71(9):536-7. PubMed ID: 8999136
    [No Abstract] [Full Text] [Related]

  • 2. [In vitro anti-MAC activities of new quinolones in focus (2)].
    Kawahara S, Eirei J.
    Kekkaku; 1996 Sep; 71(9):537-9. PubMed ID: 8999137
    [No Abstract] [Full Text] [Related]

  • 3. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract] [Full Text] [Related]

  • 4. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
    Sato K, Tomioka H.
    Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. N1-phenyl substituted 4-quinolones of tuberculostatic activity.
    Holzgrabe U, Steinert M.
    Pharmazie; 2001 Nov; 56(11):850-1. PubMed ID: 11817167
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A, Reddy KS, Ahmed SK, Khan MN, Sinha RK, Yadav JS, Arora SK.
    Bioorg Med Chem; 2006 Feb 01; 14(3):650-8. PubMed ID: 16203154
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates.
    Vanitha JD, Paramasivan CN.
    Diagn Microbiol Infect Dis; 2004 Jul 01; 49(3):179-82. PubMed ID: 15246507
    [Abstract] [Full Text] [Related]

  • 11. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.
    Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS.
    J Infect Dis; 2003 Jun 15; 187(12):1977-80. PubMed ID: 12792877
    [Abstract] [Full Text] [Related]

  • 12. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A, Soltani F, Moshafi MH.
    Boll Chim Farm; 2002 Jun 15; 141(5):394-6. PubMed ID: 12481384
    [Abstract] [Full Text] [Related]

  • 13. Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies.
    Klopman G, Wang S, Jacobs MR, Ellner JJ.
    Antimicrob Agents Chemother; 1993 Sep 15; 37(9):1807-15. PubMed ID: 8239588
    [Abstract] [Full Text] [Related]

  • 14. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
    Kamala T, Herbert D, Venkatesan P, Paramasivan CN.
    Int J Lepr Other Mycobact Dis; 1997 Sep 15; 65(3):375-8. PubMed ID: 9401493
    [Abstract] [Full Text] [Related]

  • 15. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
    Barluenga J, Aznar F, García AB, Cabal MP, Palacios JJ, Menéndez MA.
    Bioorg Med Chem Lett; 2006 Nov 15; 16(22):5717-22. PubMed ID: 16987658
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
    Cai S, Sato K, Shimizu T, Yamabe S, Hiraki M, Sano C, Tomioka H.
    J Antimicrob Chemother; 2006 Jan 15; 57(1):85-93. PubMed ID: 16303883
    [Abstract] [Full Text] [Related]

  • 18. [In vitro antimycobacterial activities of a new quinolone, balofloxacin].
    Kawahara S, Tada A, Nagare H.
    Kekkaku; 2001 Jan 15; 76(1):29-31. PubMed ID: 11211780
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.